CA3030268A1 — Body-associated receiver and method
Assigned to Otsuka Pharmaceutical Co Ltd · Expires 2010-07-01 · 16y expired
What this patent protects
Receivers, which may be external or implantable, are provided, which are configured to receive data with respect to one or more parameters of a subject. Aspects of receivers of the invention include the presence of one or more of: a power source configured for mounting on an exte…
USPTO Abstract
Receivers, which may be external or implantable, are provided, which are configured to receive data with respect to one or more parameters of a subject. Aspects of receivers of the invention include the presence of one or more of: a power source configured for mounting on an exterior surface of the subject; a power management module electrically coupled to the power source; a processing unit electrically coupled to the power management module; and a communication module electrically coupled to the processing unit, wherein the receiver is configured to provide physiological information to an external second device and to provide control information to a third device located external to the subject. Receivers of the invention may be configured to receive a conductively transmitted signal. Also provided are systems that include the receivers, methods of using the same, and systems and methods for using a receiver for coordinating with dosage delivery systems.
Drugs covered by this patent
- Abilify (aripiprazole) · Generic (originally Otsuka/BMS)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.